Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEO

Neogenomics Inc

Dec 05 • 04:00PM ET

11.90

-0.27 -2.22 %

Healthcare • Diagnostics & Research • USA • NASD

Peers: ILMN LH DGX BIO QGEN EXAS NVCR GH TMO A

| Held by: IJR VTI IWM VB VBK SPSM VXF IWN IJS SCHA

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.89	Insider Own	4.86%	Shs Outstand	128.89M	Perf Week	-1.65%
Market Cap	1.54B	Forward P/E	72.39	EPS next Y	0.16	Insider Trans	0.27%	Shs Float	123.10M	Perf Month	14.09%
Enterprise Value	1.79B	PEG	-	EPS next Q	0.04	Inst Own	97.04%	Short Float	6.84%	Perf Quarter	50.06%
Income	-113.47M	P/S	2.17	EPS this Y	-14.86%	Inst Trans	-1.25%	Short Ratio	2.55	Perf Half Y	60.38%
Sales	709.16M	P/B	1.83	EPS next Y	75.53%	ROA	-7.52%	Short Interest	8.42M	Perf YTD	-27.79%
Book/sh	6.50	P/C	9.38	EPS next 5Y	45.20%	ROE	-12.99%	52W High	19.11 -37.75%	Perf Year	-33.22%
Cash/sh	1.27	P/FCF	-	EPS past 3/5Y	-107.48% -	ROIC	-9.12%	52W Low	4.72 152.12%	Perf 3Y	6.16%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	10.90% 10.07%	Gross Margin	40.90%	Volatility	3.22% 4.76%	Perf 5Y	-74.99%
Dividend TTM	-	EV/Sales	2.52	EPS Y/Y TTM	-44.29%	Oper. Margin	-10.38%	ATR (14)	0.50	Perf 10Y	48.19%
Dividend Ex-Date	-	Quick Ratio	3.62	Sales Y/Y TTM	10.10%	Profit Margin	-16.00%	RSI (14)	64.68	Recom	2.29
Dividend Gr. 3/5Y	- -	Current Ratio	3.91	EPS Q/Q	-51.58%	SMA20	6.87%	Beta	1.57	Target Price	12.50
Payout	-	Debt/Eq	0.49	Sales Q/Q	11.90%	SMA50	16.60%	Rel Volume	0.27	Prev Close	12.17
Employees	2200	LT Debt/Eq	0.48	Earnings	Oct 28 BMO	SMA200	39.55%	Avg Volume	3.30M	Price	11.90
IPO	Nov 10, 1999	Option/Short	Yes / Yes	EPS/Sales Surpr.	46.34% 2.22%	Trades		Volume	898,730	Change	-2.22%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-30-25	Downgrade	BTIG Research	Buy → Neutral
Jul-29-25	Downgrade	William Blair	Outperform → Mkt Perform
May-15-25	Initiated	Guggenheim	Neutral
Apr-30-25	Downgrade	Leerink Partners	Outperform → Market Perform	$9
Jan-13-25	Downgrade	The Benchmark Company	Buy → Hold
Dec-10-24	Initiated	Jefferies	Buy	$22
May-01-24	Resumed	Craig Hallum	Buy	$26
Dec-29-23	Reiterated	BTIG Research	Buy	$25 → $21
Aug-21-23	Upgrade	Stephens	Equal-Weight → Overweight	$18
May-16-23	Downgrade	Raymond James	Outperform → Mkt Perform
May-09-23	Upgrade	BTIG Research	Neutral → Buy	$25
Feb-24-23	Upgrade	The Benchmark Company	Hold → Buy	$20
Feb-01-23	Upgrade	Needham	Hold → Buy	$15
Aug-26-22	Downgrade	The Benchmark Company	Buy → Hold
Aug-22-22	Downgrade	Needham	Buy → Hold
Jun-03-22	Initiated	Piper Sandler	Overweight	$13
Mar-29-22	Downgrade	Stephens	Overweight → Equal-Weight	$34 → $16
Mar-29-22	Downgrade	BofA Securities	Buy → Neutral	$25 → $18
Jan-18-22	Resumed	Stephens	Overweight	$40
Dec-16-21	Initiated	Cowen	Outperform	$42

Show Previous Ratings

Dec-05-25 11:19AM	Testing & Diagnostics Services Stocks Q3 Recap: Benchmarking NeoGenomics (NASDAQ:NEO) (StockStory)
Nov-21-25 06:36PM	NeoGenomics, Fortrea, and Acadia Healthcare Shares Skyrocket, What You Need To Know (StockStory) +8.30%
Nov-06-25 07:05AM	NeoGenomics to Participate in Upcoming Investor Conferences (Business Wire)
Nov-04-25 12:38AM	The Top 5 Analyst Questions From NeoGenomics's Q3 Earnings Call (StockStory)
Nov-03-25 11:01PM	NeoGenomics (NEO): Buy, Sell, or Hold Post Q3 Earnings? (StockStory)
12:51PM	Loading…
Oct-30-25 12:51PM	NeoGenomics to Present RaDaR ST Bridging Study at ISLB 2025, Demonstrating Reliable MRD Detection Across Solid Tumors (Business Wire) -5.74%
Oct-29-25 01:33AM	NEO Q3 Deep Dive: Clinical Volume Gains and New Product Launches Shape Outlook (StockStory)
Oct-28-25 12:11PM	Why NeoGenomics (NEO) Stock Is Trading Up Today (StockStory)
08:15AM	NeoGenomics (NEO) Surpasses Q3 Earnings and Revenue Estimates (Zacks)
07:49AM	NeoGenomics's (NASDAQ:NEO) Q3 Sales Top Estimates, Stock Soars (StockStory)
07:15AM	NeoGenomics: Q3 Earnings Snapshot (Associated Press Finance)
07:05AM	NeoGenomics Reports Third Quarter 2025 Results (Business Wire)
Oct-26-25 11:15PM	NeoGenomics (NEO) Reports Earnings Tomorrow: What To Expect (StockStory)
Oct-24-25 12:39AM	3 Healthcare Stocks Walking a Fine Line (StockStory)
Oct-23-25 07:10AM	Armata Pharmaceuticals (ARMP) Surges 103.2%: Is This an Indication of Further Gains? (Zacks)
03:54AM	Loading…
Oct-16-25 03:54AM	NeoGenomics (NEO) Moves 6.3% Higher: Will This Strength Last? (Zacks)
Oct-14-25 07:05AM	NeoGenomics to Highlight RaDaR ST MRD Assay at ESMO Congress 2025 (Business Wire)
Oct-07-25 07:05AM	NeoGenomics to Report Third Quarter 2025 Financial Results on October 28, 2025 (Business Wire)
Sep-24-25 09:10AM	Here's Alger Weatherbie Specialized Growth Fund's Comment on NeoGenomics (NEO) (Insider Monkey)
Sep-10-25 04:35PM	Why NeoGenomics (NEO) Shares Are Falling Today (StockStory) +11.50%
Sep-04-25 09:36AM	Brown Advisory Small-Cap Growth Strategy Sold Neogenomics (NEO) Following the News of CEO Departure (Insider Monkey)
Sep-02-25 09:30AM	Breakthrough Cancer Therapies Fuel Regulatory Momentum as Global Market Expands (PR Newswire)
Aug-29-25 05:05PM	Health Care Roundup: Market Talk (The Wall Street Journal) +21.78%
01:46PM	Why Is NeoGenomics (NEO) Stock Soaring Today (StockStory)
01:04PM	NeoGenomics Gains 'Unexpected' Win As Court Rejects Natera Claims (Benzinga)
Aug-26-25 08:42AM	Tempus' Key Acquisitions Strengthen Its AI Healthcare Leadership (Zacks)
Aug-20-25 11:36PM	Testing & Diagnostics Services Stocks Q2 Teardown: NeoGenomics (NASDAQ:NEO) Vs The Rest (StockStory)
Aug-13-25 05:51PM	NeoGenomics, Progyny, Repligen, Revvity, and Waters Corporation Shares Are Soaring, What You Need To Know (StockStory)
Aug-12-25 12:56AM	NEO Q2 Deep Dive: Guidance Reset Amid Pharma Weakness, Delayed Product Launches (StockStory)
12:39AM	NeoGenomics's Q2 Earnings Call: Our Top 5 Analyst Questions (StockStory)
03:36PM	Loading…
Aug-07-25 03:36PM	Why NeoGenomics (NEO) Stock Is Trading Up Today (StockStory)
Jul-30-25 09:55AM	Down 29.2% in 4 Weeks, Here's Why NeoGenomics (NEO) Looks Ripe for a Turnaround (Zacks)
09:40AM	Peloton upgraded, Booking downgraded: Wall Street's top analyst calls (The Fly)
07:05AM	NeoGenomics Launches PanTracer LBx, Expanding Access to Comprehensive Genomic Profiling with Liquid Biopsy (Business Wire)
05:07AM	Fort Myers-based NeoGenomics sees stock plunge after reporting mixed results for Q2 (The News-Press)
Jul-29-25 02:26PM	Why NeoGenomics (NEO) Shares Are Falling Today (StockStory) -18.73%
08:15AM	NeoGenomics (NEO) Meets Q2 Earnings Estimates (Zacks)
07:57AM	NeoGenomics (NASDAQ:NEO) Misses Q2 Sales Targets, Stock Drops 15.8% (StockStory)
07:14AM	NeoGenomics: Q2 Earnings Snapshot (Associated Press Finance)
07:05AM	NeoGenomics Reports Second Quarter 2025 Results (Business Wire)
Jul-27-25 11:08PM	NeoGenomics (NEO) Reports Q2: Everything You Need To Know Ahead Of Earnings (StockStory)
Jul-24-25 10:00AM	Analysts Estimate Amicus Therapeutics (FOLD) to Report a Decline in Earnings: What to Look Out for (Zacks)
Jul-14-25 11:31PM	Q1 Earnings Highlights: NeoGenomics (NASDAQ:NEO) Vs The Rest Of The Testing & Diagnostics Services Stocks (StockStory)
Jul-11-25 03:30PM	NeoGenomics, RadNet, Pediatrix Medical Group, Penumbra, and Neogen Shares Plummet, What You Need To Know (StockStory)
Jul-02-25 08:49AM	Here's Why NeoGenomics (NEO) Sold Off in Q1 (Insider Monkey)
Jul-01-25 07:05AM	NeoGenomics to Report Second Quarter 2025 Financial Results on July 29, 2025 (Business Wire)
Jun-30-25 07:05AM	NeoGenomics Announces PanTracer Tissue and PanTracer Tissue + HRD Now Available to Support More Informed and Timely Cancer Care (Business Wire)
Jun-24-25 04:27PM	3 Hot Trades for Insiders, But Are They Good Buys for Investors? (MarketBeat)
02:19PM	5 Insightful Analyst Questions From NeoGenomics's Q1 Earnings Call (StockStory)
07:05AM	NeoGenomics Appoints Dr. Marjorie Green to Board of Directors (Business Wire)
May-28-25 07:10AM	NeoGenomics Debuts PanTracer Family of Genomic Profiling Tests at ASCO 2025 (Business Wire)
May-23-25 10:09AM	NeoGenomics introduces c-MET companion diagnostic for NSCLC (Medical Device Network)
May-22-25 07:10AM	NeoGenomics Launches c-MET CDx Assay to Guide Treatment Decisions for Advanced Non-Small Cell Lung Cancer (Business Wire)
May-20-25 07:05AM	NeoGenomics to Participate in Upcoming June Investor Conferences (Business Wire)
12:40AM	3 Healthcare Stocks with Mounting Challenges (StockStory)
May-06-25 09:30AM	It's Not Too Late to Jump on These Under-the-Radar Momentum Plays (MarketBeat)
May-05-25 12:34AM	3 Small-Cap Stocks Walking a Fine Line (StockStory)
May-01-25 11:55AM	NeoGenomics price target lowered to $10 from $17 at Morgan Stanley (TipRanks) +13.53%
07:05AM	NeoGenomics Pays Off 1.25% Convertible Senior Notes (Business Wire)
Apr-30-25 09:00AM	NeoGenomics Q1 Earnings: The Stock Price Drop Is A Gift (Rating Upgrade) (Seeking Alpha)
03:09AM	NeoGenomics Inc (NEO) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Apr-29-25 03:49PM	Why NeoGenomics (NEO) Stock Is Nosediving (StockStory) -34.00%
12:18PM	NeoGenomics, Inc (NEO) Q1 2025 Earnings Call Transcript (Seeking Alpha)
08:40AM	NeoGenomics (NEO) Reports Break-Even Earnings for Q1 (Zacks)
08:00AM	NeoGenomics and Ultima Genomics collaborate to expand clinical test offerings in Oncology using the UG 100 sequencing platform (PR Newswire)
07:56AM	NeoGenomics (NASDAQ:NEO) Misses Q1 Sales Targets, Stock Drops (StockStory)
07:42AM	NeoGenomics: Q1 Earnings Snapshot (Associated Press Finance)
07:30AM	NeoGenomics Reports First Quarter 2025 Results (Business Wire)
Apr-28-25 03:01AM	NeoGenomics (NEO) Q1 Earnings Report Preview: What To Look For (StockStory)
Apr-23-25 10:01AM	Analysts Estimate GSK (GSK) to Report a Decline in Earnings: What to Look Out for (Zacks)
Apr-22-25 10:00AM	NeoGenomics (NEO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
07:05AM	NeoGenomics to Showcase PanTracer LBx Validation Study at AACR Annual Meeting (Business Wire)
Apr-08-25 07:05AM	NeoGenomics to Report First Quarter 2025 Financial Results on April 29, 2025 (Business Wire) -7.13%
Apr-07-25 07:05AM	NeoGenomics Completes Acquisition of Pathline (Business Wire)
Apr-03-25 05:06AM	Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking NeoGenomics (NASDAQ:NEO) (StockStory) -7.43%
Apr-01-25 07:05AM	Tony Zook Assumes Role as Chief Executive Officer of NeoGenomics (Business Wire)
Mar-21-25 05:10AM	3 Reasons to Sell NEO and 1 Stock to Buy Instead (StockStory)
Mar-18-25 07:05AM	NeoGenomics Appoints Warren Stone as President & Chief Operating Officer (Business Wire)
Mar-14-25 05:08AM	Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking Quest (NYSE:DGX) (StockStory)
Mar-12-25 12:43PM	3 Small-Cap Stocks in Hot Water (StockStory) -5.97%
Mar-10-25 07:00AM	NeoGenomics Expands Oncology Testing Reach in the Northeast with Acquisition of Pathline (Business Wire) -10.05%
Feb-28-25 08:02AM	3 Healthcare Stocks Skating on Thin Ice (StockStory)
Feb-24-25 07:05AM	NeoGenomics to Participate in Upcoming Investor Conferences (Business Wire)
Feb-19-25 02:03AM	NeoGenomics Inc (NEO) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Feb-18-25 11:33PM	Q4 2024 Neogenomics Inc Earnings Call (Thomson Reuters StreetEvents) -13.97%
12:46PM	Why NeoGenomics (NEO) Shares Are Trading Lower Today (StockStory)
08:15AM	NeoGenomics (NEO) Tops Q4 Earnings Estimates (Zacks)
07:24AM	NeoGenomics: Q4 Earnings Snapshot (Associated Press Finance)
07:13AM	NeoGenomics (NASDAQ:NEO) Misses Q4 Sales Targets (StockStory)
07:05AM	NeoGenomics Reports Fourth Quarter and Full Year 2024 Results (Business Wire)
Feb-17-25 08:13AM	NeoGenomics (NEO) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
Feb-12-25 09:56AM	Q4 2024 Adaptive Biotechnologies Corp Earnings Call (Thomson Reuters StreetEvents)
Jan-30-25 09:05AM	PacBio Announces Appointment of Chris Smith to Board of Directors (GlobeNewswire)
Jan-29-25 08:05AM	NeoGenomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 18, 2025 (Business Wire)
Jan-15-25 04:24PM	NeoGenomics Is On The Upswing, Reversing A CEO-Tied Sell-Off, On Bullish Long-Term Guidance (Investor's Business Daily) +6.75%
10:10AM	Cutting-Edge Cancer Therapies Lead the Way into a Transformative Year (PR Newswire)
07:05AM	NeoGenomics Provides 2025 Financial Guidance and Updates Long-Range Financial Plan (Business Wire)
04:53AM	NeoGenomics (NEO) Surges 9.1%: Is This an Indication of Further Gains? (Zacks)
Jan-14-25 07:30AM	Adaptive Biotechnologies and NeoGenomics Partner to Expand Access to Personalized Disease Monitoring for Blood Cancer Patients (GlobeNewswire) +9.11%
Jan-10-25 07:05AM	NeoGenomics Announces Chief Executive Officer Succession (Business Wire) -20.63%

NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Olivo Alicia C	EVP, GC & Business Development	Nov 25 '25	Option Exercise	10.05	8,977	90,219	51,999	Nov 28 04:18 PM
Olivo Alicia C	EVP, GC & Business Development	Nov 25 '25	Sale	12.00	20,916	250,992	31,083	Nov 28 04:18 PM
ALICIA OLIVO	Officer	Nov 25 '25	Proposed Sale	11.61	11,939	138,612		Nov 25 04:27 PM
ALICIA OLIVO	Officer	Oct 16 '25	Proposed Sale	9.97	4,918	49,032		Oct 16 04:22 PM
Sherman Jeffrey Scott	Chief Financial Officer	Aug 06 '25	Buy	5.62	20,000	112,322	188,332	Aug 06 04:07 PM
Zook Anthony P.	Chief Executive Officer	Aug 06 '25	Buy	5.58	17,900	99,954	38,066	Aug 06 04:07 PM
Williams Felicia	Director	Jun 01 '25	Option Exercise	0.00	7,160	0	7,160	Jun 03 04:08 PM
KANOVSKY STEPHEN M	Director	Jun 01 '25	Option Exercise	0.00	12,254	0	52,344	Jun 03 04:08 PM
Kelly Michael Aaron	Director	Jun 01 '25	Option Exercise	0.00	12,254	0	44,009	Jun 03 04:08 PM
TETRAULT LYNN A.	Director	Jun 01 '25	Option Exercise	0.00	12,254	0	73,652	Jun 03 04:07 PM
Floegel Elizabeth	Director	Jun 01 '25	Option Exercise	0.00	12,254	0	23,590	Jun 03 04:07 PM
Gunn Neil	Director	Jun 01 '25	Option Exercise	0.00	12,254	0	28,100	Jun 03 04:07 PM
Zook Anthony P.	Chief Executive Officer	Jun 01 '25	Option Exercise	0.00	12,254	0	23,590	Jun 03 04:06 PM
Perez David Brian	Director	Jun 01 '25	Option Exercise	0.00	12,254	0	33,890	Jun 03 04:06 PM
Kelly Michael Aaron	Director	May 27 '25	Buy	7.60	5,000	38,000	5,000	May 28 04:07 PM
Olivo Alicia C	EVP, GC & Business Development	May 11 '25	Option Exercise	0.00	6,503	0	51,204	May 13 04:06 PM
Sherman Jeffrey Scott	Chief Financial Officer	May 11 '25	Option Exercise	0.00	13,005	0	171,499	May 13 04:06 PM
Stone Warren	Pres & Chief Operating Officer	May 11 '25	Option Exercise	0.00	9,613	0	104,921	May 13 04:05 PM
Stone Warren	Pres & Chief Operating Officer	May 12 '25	Buy	8.58	5,700	48,895	108,280	May 13 04:05 PM
TETRAULT LYNN A.	Director	May 09 '25	Buy	8.14	7,000	56,974	7,000	May 09 05:26 PM
KANOVSKY STEPHEN M	Director	May 07 '25	Buy	7.78	4,000	31,124	40,090	May 09 05:24 PM
Zook Anthony P.	Chief Executive Officer	May 06 '25	Buy	7.88	18,900	148,919	18,900	May 08 04:13 PM
Perez David Brian	Director	May 05 '25	Buy	7.63	10,000	76,300	10,000	May 07 04:05 PM
Gunn Neil	Director	May 05 '25	Buy	7.75	4,510	34,977	15,846	May 07 04:05 PM
Sherman Jeffrey Scott	Chief Financial Officer	May 02 '25	Buy	7.51	20,000	150,104	158,494	May 06 04:08 PM
Stone Warren	Pres & Chief Operating Officer	May 02 '25	Option Exercise	0.00	5,969	0	96,762	May 06 04:07 PM
Aunan Greg D	Chief Accounting Officer	May 02 '25	Option Exercise	0.00	5,372	0	18,888	May 05 04:06 PM
Olivo Alicia C	EVP, GC & Business Development	Feb 23 '25	Option Exercise	0.00	8,443	0	47,857	Feb 25 04:41 PM
Harris Melody	Chf Ops Off, Pres, Informatics	Feb 23 '25	Option Exercise	0.00	8,443	0	111,811	Feb 25 04:40 PM
Stone Warren	Chief Commerical Officer	Feb 23 '25	Option Exercise	0.00	8,443	0	93,265	Feb 25 04:39 PM
Sherman Jeffrey Scott	Chief Financial Officer	Feb 23 '25	Option Exercise	0.00	15,535	0	141,271	Feb 25 04:38 PM
Smith Christopher M	Chief Executive Officer	Feb 23 '25	Option Exercise	0.00	57,413	0	655,652	Feb 25 04:37 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NEO

Neogenomics Inc

Upgrade your FINVIZ experience